The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...

New epinephrine nasal spray dosage approved for pediatrics; FDA agree to review semaglutide for weight management; wearable defibrillator cleared to prevent sudden cardiac arrest; a low dose ...

HealthDay News — North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge, the Associated Press is reporting.

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.

In a recent study, protective association lasted for up to eight years, with greatest reduction seen at two to three years postvaccination.

The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS -mutated recurrent ...

Nirsevimab associated with lower odds of RSV-related hospitalization, ICU admission, lower respiratory tract infection incidence.

The prescription device is a wearable belt that includes a motor designed to transmit low amplitude, high frequency vibration to the spine and hips.

The US Food and Drug Administration has chosen Dr Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

Terminations resulted in $1.81 billion in terminated grant funding; 30% had not been expended at time of termination.